Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X O Breakefield

Showing results (31-40 of 264) with videos related to

Pageof 27
Sort By:
Journal of Neurochemistry|July 1, 1978
The catechol estrogen, 2-hydroxyestradiol, inhibits catechol-O-methyltransferase activity in neuroblastoma cellsT Lloyd, J Weisz, X O Breakefield
The Journal of Gene Medicine|July 14, 2000
Prodrug activation enzymes in cancer gene therapyM Aghi, F Hochberg, X O Breakefield
Neoplasia (New York, N.Y.)|August 10, 2000
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applicationsA Jacobs, X O Breakefield, C Fraefel
Biochemical Pharmacology|January 1, 1979
Distinct forms of monoamine oxidase expressed in hepatoma and HeLa cells in cultureM R Castro Costa, X O Breakefield
Restorative Neurology and Neuroscience|May 10, 2011
Virus vectors for gene delivery to the nervous systemF Smith, D Jacoby, X O Breakefield
Brain Pathology (Zurich, Switzerland)|October 1, 1992
The autosomal dominant dystoniasT Gasser, S Fahn, X O Breakefield
Neoplasia (New York, N.Y.)|August 10, 2000
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesisA Jacobs, X O Breakefield, C Fraefel
The Biochemical Journal|October 15, 1978
Regulation of synthesis of guanosine 3':5'-cyclic monophosphate in neuroblastoma cellsT Bartfai, X O Breakefield, P Greengard
Genomics|January 1, 1992
Highly polymorphic (GT)n repeat sequence in intron II of the human MAOB geneC Konradi, L Ozelius, X O Breakefield
Gene Therapy|February 24, 1998
Hybrid vectors: a new generation of virus-based vectors designed to control the cellular fate of delivered genesD R Jacoby, C Fraefel, X O Breakefield
Pageof 27

Showing results (31-40 of 264) with videos related to

Sort By:
Pageof 27
Journal of Neurochemistry|July 1, 1978
The catechol estrogen, 2-hydroxyestradiol, inhibits catechol-O-methyltransferase activity in neuroblastoma cellsT Lloyd, J Weisz, X O Breakefield
The Journal of Gene Medicine|July 14, 2000
Prodrug activation enzymes in cancer gene therapyM Aghi, F Hochberg, X O Breakefield
Neoplasia (New York, N.Y.)|August 10, 2000
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applicationsA Jacobs, X O Breakefield, C Fraefel
Biochemical Pharmacology|January 1, 1979
Distinct forms of monoamine oxidase expressed in hepatoma and HeLa cells in cultureM R Castro Costa, X O Breakefield
Restorative Neurology and Neuroscience|May 10, 2011
Virus vectors for gene delivery to the nervous systemF Smith, D Jacoby, X O Breakefield
Brain Pathology (Zurich, Switzerland)|October 1, 1992
The autosomal dominant dystoniasT Gasser, S Fahn, X O Breakefield
Neoplasia (New York, N.Y.)|August 10, 2000
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesisA Jacobs, X O Breakefield, C Fraefel
The Biochemical Journal|October 15, 1978
Regulation of synthesis of guanosine 3':5'-cyclic monophosphate in neuroblastoma cellsT Bartfai, X O Breakefield, P Greengard
Genomics|January 1, 1992
Highly polymorphic (GT)n repeat sequence in intron II of the human MAOB geneC Konradi, L Ozelius, X O Breakefield
Gene Therapy|February 24, 1998
Hybrid vectors: a new generation of virus-based vectors designed to control the cellular fate of delivered genesD R Jacoby, C Fraefel, X O Breakefield
Pageof 27